In collaboration with its newly minted Chinese partner, Kiwi drug developer and marketer AFT Pharmaceuticals (ASX:AFP) plans ...

“Our data shows that as many as 20% of breast cancer survivors on aromatase inhibitors will stop taking their medication ...

The early stages of chronic kidney disease (CKD) are usually asymptomatic, with kidney function progressively and ...

Hyponatraemia is a frequent complication after joint replacement surgeries, often arising from fluid and electrolyte ...

Everyone’s suddenly obsessed with the pelvic floor—physical therapists, MAHA influencers, me. Could this deeply misunderstood ...

Several supplements may help with perimenopausal symptoms, such as hot flashes, night sweats, sleep disturbance, depression, ...

Men diagnosed with prostate cancer have traditionally faced two choices: do nothing and hope the tumor doesn’t grow between ...

Forget cramps, cranky moods and a craving for chocolate. Now, periods can mean acquiring a crazy glow for your skin — that is ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Minnesota medtech giant Medtronic found positive momentum Tuesday morning as it faced down what top executives see as a ...